Request Study Information

After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.

A Phase 2, Double-blind, Randomized, Active-controlled Evaluation of the Safety, Tolerability, Pharmacokinetics and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug-Resistant E. Coli

This study evaluates an investigational treatment called LBP-EC01, which uses bacteriophages (viruses that target bacteria) to treat acute UTIs caused by drug-resistant E. coli. Participants will receive either the study drug or a placebo, both alongside standard antibiotic therapy. The goal is to find a safe and more effective way to treat UTIs when traditional antibiotics may not work.

Eligibility:
• Adults with a recent history of UTIs caused by drug-resistant E. coli
• Currently experiencing an uncomplicated UTI
• Not currently taking antibiotics to treat this infection

Enter Your Information

(All fields are required)

Study Request Form (specific)

Name(Required)
Date of Birth(Required)
Race(Required)
Select one or more options that best describe you. This information can help ensure that all populations are represented in research.

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from ECIR and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to ECIR’s privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.